Stutz; Anton

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stutz; Anton.The latest application filed is for "selective glucocorticoid receptor modifiers for treating impaired skin wound healing".

Company Profile

0.2.15

Stutz; Anton - Altmunster AT
STUTZ; Anton - Wien AT
Stutz, Anton - Vienna AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of skin disorders Grant 11,414,426 - Fabbro , et al. August 16, 2	2022-08-16
Selective Glucocorticoid Receptor Modifiers For Treating Impaired Skin Wound Healing App 20220047602 - WOLFF-WINISKI; Barbara ; et al.	2022-02-17
Treatment Of Skin Disorders App 20210107913 - FABBRO; Doriano ; et al.	2021-04-15
PARP Inhibitor in Combination with a Glucocorticoid and/or Ascorbic Acid and/or a Protein Growth Factor for the Treatment of Imp App 20200129476 - WOLFF-WINISKI; BARBARA ; et al.	2020-04-30
Rucaparib, Talazoparib, Veliparib, Olaparib and AZD 2461 for Treating Impaired Skin Wound Healing App 20200078369 - WOLFF-WINISKI; BARBARA ; et al.	2020-03-12
Methods For Identifying A Non-healing Skin Wound And For Monitoring The Healing Of A Skin Wound App 20200025746 - Wolff-Winiski; Barbara ; et al.	2020-01-23
Combinations Comprising a VEGF Receptor Inhibitor App 20120172386 - BILLICH; Andreas ; et al.	2012-07-05
Pharmaceutical Compositions and Solid Forms App 20110112121 - BERGHAUSEN; Joerg ; et al.	2011-05-12
Combinations Comprising a Vegf Receptor Inhibitor App 20080306058 - Billich; Andreas ; et al.	2008-12-11
Pharmaceutical compositions containing terbinafin and use thereof App 20080286356 - Alles; Rainer ; et al.	2008-11-20
Pharmaceutical composition comprising a macrolide immunomodulator App 20080132534 - GRASSBERGER; Maximilian ; et al.	2008-06-05
Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials App 20070117764 - Grassberger; Maximilian ; et al.	2007-05-24
Pharmaceutical composition comprising a macrolide immunomodulator App 20070021377 - Grassberger; Maximilian ; et al.	2007-01-25
Synergistic combinations of macrolide t-cell modulator or immunosuppressant and a retinoid App 20060100187 - Grassberger; Maximilian ; et al.	2006-05-11
New use of 11.28-dioxa-4-azatricyclo [22.3.1.04,9] octacos-18-ene derivatives and pharmaceutical compositions containing them App 20050059694 - Grassberger, Maximimilian ; et al.	2005-03-17
Pharmaceutical compositions containig terbinafin and use thereof App 20040198838 - Alles, Rainer ; et al.	2004-10-07
Use of 11,28-dioxa-4-azatricyclo[22.3.1.0.sup.4,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them Grant 5,665,727 - Grassberger , et al. September 9, 1	1997-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.